Affinity DataKi: 0.440nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 1.10nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 1.20nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 1.40nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 1.70nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 2.20nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 2.5nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 2.90nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 2.90nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 4.30nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 27nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
Affinity DataKi: 157nMAssay Description:Inhibition of [3H]-pentazocine binding to Sigma opioid receptor type 1More data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 220nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 280nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 870nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 910nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 1.15E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 1.17E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 1.18E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 1.29E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 1.32E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 1.37E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 1.92E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 2.03E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataKi: 2.63E+3nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Institute For Life Science Research
Curated by ChEMBL
Institute For Life Science Research
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Binding affinity for human growth hormone secretagogue receptor was determined using [125I]-ghrelinMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 6.80nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 68nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 78nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 82nMAssay Description:Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Asahi Kasei Pharma
Curated by ChEMBL
Asahi Kasei Pharma
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of human PDE4B1 incubated for 10 mins using cAMP and [3H]cAMP substratesMore data for this Ligand-Target Pair